Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Recruiting now

Conditions studied: Melanoma

In brief

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Key facts

Study ID

NCT01205815

Run by

Vanderbilt-Ingram Cancer Center

People needed

3000

Starts

2010-06-03

Expected to finish

2027-06-01

Last updated by the study team

2025-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically-proven diagnosis of melanoma.
• Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

You may not qualify if…

• Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
• Any patient unable or unwilling to provide consent.

Where it is running

• Vanderbitl-Ingram Cancer Center — Nashville, Tennessee, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.